Label: SODIUM CHLORIDE irrigant

  • NDC Code(s): 0338-0051-44
  • Packager: Baxter Healthcare Corporation
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated April 2, 2018

If you are a consumer or patient please visit this version.

  • DESCRIPTION

    0.9% Sodium Chloride Irrigation, USP in the Baxter Sterile Container System is a sterile, nonpyrogenic, isotonic solution for the preparation of slushed solution. It contains no antimicrobial agents. Composition, osmolarity, pH and ionic concentration are shown in Table 1.

    Table 1

    Size (mL)

    Composition (g/L)

    Osmolarity (mOsmol/L) (calc)

    pH

    Ionic Concentration
    (mEq/L)

    Sodium Chloride, USP (NaCl)

    Sodium

    Chloride

    0.9 % Sodium Chloride Irrigation, USP

    1000

    9

    308

    5.0 (4.5 to 7.0)

    154

    154

    The Baxter Sterile Container System is designed to provide a slush container with a sterile exterior surface for use within the surgical field. Within the overwrap, the unit is packaged in a dispensing bag which maintains the sterility of this surface.

    The flexible plastic slush container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by culture toxicity studies.

  • CLINICAL PHARMACOLOGY

    Slushed solution is used to induce regional hypothermia in conditions such as certain open heart and kidney surgical procedures by direct application of slushed solution. The objective of regional hypothermia is to reduce cellular metabolic activity so that body tissues can tolerate a period of total or relative ischemia thereby inhibiting the formation and buildup of destructive autolytic enzymes and anaerobic by-products usually produced and accumulated in ischemic tissues.

  • INDICATIONS AND USAGE

    Slushed solution is used to create regional hypothermia in order to reduce and minimize manifestations of warm-temperature ischemia. Temperature probes may be used to determine requirements for replacement or addition of slushed solution.

  • CONTRAINDICATIONS

    None known

  • WARNINGS

    Not for injection. For use in slush preparation for regional hypothermia.

  • PRECAUTIONS

    General Precautions

    Avoid prolonged direct contact between ice crystals and body tissues.

    Experience in use of slushed solutions in pediatrics is limited.

    Carcinogenesis, Mutagenesis, Impairment of Fertility

    Studies performed with slushed 0.9% Sodium Chloride Irrigation, USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

    Pregnancy

    Teratogenic Effects

    Animal reproduction studies have not been conducted with slushed 0.9% Sodium Chloride Irrigation, USP. It is also not known whether slushed 0.9% Sodium Chloride Irrigation, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Slushed 0.9% Sodium Chloride Irrigation, USP should be given to a pregnant woman only if clearly needed.

    Nursing Mothers

    It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when slushed 0.9% Sodium Chloride Irrigation, USP is administered to a nursing mother.

    Pediatric Use

    Safety and effectiveness of slushed 0.9% Sodium Chloride Irrigation, USP in pediatric patients have not been established by adequate and well controlled trials; however, the use of electrolyte solutions in the pediatric population is referenced in the medical literature. The warnings, precautions and adverse reactions identified in the label copy should be observed in the pediatric population.

    Do not administer unless seals of outer dispensing bag are intact.

  • ADVERSE REACTIONS

    No serious adverse reactions are known.

  • DOSAGE AND ADMINISTRATION

    The volume of slushed solution required will vary with patient’s age, clinical condition, cooling effect desired and duration of cooling effect desired, according to physician’s instructions.

  • HOW SUPPLIED/STORAGE AND HANDLING

    .9% Sodium Chloride Irrigation, USP in the Baxter Sterile Container System is supplied as follows:

    Code

    Size (mL)

    NDC

    DIN

    2B7231

    1000

    0338-0051-44

    786160

    Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Avoid freezing except during controlled slushing procedure. It is recommended that this product be stored at room temperature (25ºC); brief exposure up to 40ºC does not adversely affect this product.

  • DIRECTIONS FOR USE OF THE BAXTER STERILE CONTAINER SYSTEM

    Guidelines for Preparation of Slush

    The following instructions are intended only as guidelines for the preparation of slush using the Baxter Sterile Container System. The specific procedure necessary to achieve the desired slush consistency will depend on the type of freezer used, location of the product in the freezer, and the utilization of freezer capacity.

    1.
    Remove product from shipping carton and place in freezer at a temperature between minus 4ºC and minus 15ºC for 2 to 6 hours. Note: A pre-cooled product will require less time to slush.
    2.
    During the freezing process, remove product from freezer periodically and carefully massage to break up large frozen chunks of solution.
    3.
    Return product to freezer and repeat procedure until desired slush consistency is obtained.

    To Open: Use Aseptic Technique

    A. To prepare unit outside the surgical field.

    1.
    Tear overwrap down side at slit and remove dispensing bag which contains the slush container.
    2.
    Allow unit to stand at room temperature for approximately 10 minutes to allow container material to regain flexibility.
    3.
    Check that all the seals of the dispensing bag are intact including the tamper evident button. If any broken seals or holes are detected, discard unit as sterility may be impaired.
    4.
    Grasp tab of dispensing bag and peel open (Figure 1). Remove wrapped inner slush container.
    5.
    Grasp point of sterile transfer wrap (Figure 2), and pull forward then back to expose sterile slush container (Figure 3). Caution should be exercised to avoid touch contamination.

    B. To transfer sterile slush container to the surgical field.

    1.
    Using sterile gloved hands, remove slush container from the sterile transfer wrap (Figure 4). Place on surgical field or use immediately.
    2.
    Grasp tab at top of slush container and peel directly across the width of the container with a steady motion (Figure 5).
    3.
    Slush is ready for dispensing.
    Figure 1
    Figure 2
    Figure 3
    Figure 4
    Figure 5
  • SPL UNCLASSIFIED SECTION

    Baxter Healthcare Corporation
    Deerfield, IL 60015 USA

    Printed in USA

    Distributed in Canada by
    Baxter Corporation
    Mississauga, ON L5N OC2

    07-19-00-0323
    Rev. April 2018

    Baxter is a registered trademark of Baxter International Inc.

  • PRINCIPAL DISPLAY PANEL - PACKAGING LABELING

    Representative Container Label for 0.9% Sodium Chloride Irrigation USP

    1000 mL
    2B7231

    NDC 0338-0051-44
    Din 00786160

    NOT FOR INJECTION

    0.9% Sodium Chloride
    Irrigation, USP
    Baxter Sterile Container System

    EACH 100 mL CONTAINS 900 mg SODIUM CHLORIDE
    USP pH 5.0 (4.5 TO 7.0) mEq/L SODIUM 154
    CHLORIDE 154 OSMOLARITY 308 mOsmol/L (CALC)
    STERILE NONPYROGENIC SINGLE DOSE CONTAINER

    FOR USE ONLY IN SLUSH PREPARATION
    FOR REGIONAL HYPOTHERMIA

    SEE ACCOMPANYING DIRECTIONS FOR USE
    DOSAGE AS DIRECTED BY A PHYSICIAN
    CAUTION RX ONLY

    Baxter Logo
    Baxter Healthcare Corporation
    Deerfield IL 60015 USA

    Made in USA

    Distributed in Canada by
    Baxter Corporation
    Misissauga ON L5N 0C2

    PL 146 Plastic

    Baxter and PL 146 are trademarks of Baxter International Inc

    Sodium Chloride Representative Carton Label

    2B7231

    6-1000 ML

    BAXTER'S STERILE CONTAINER SYSTEM

    0.9% SODIUM CHLORIDE IRRIGATION, USP

    EXP
    XXXXX

    SECONDARY BAR CODE
    (17) YYMM00 (10) XXXXX

    LOT
    XXXXX

    PRIMARY BAR CODE
    (01) 50303380051446

  • INGREDIENTS AND APPEARANCE
    SODIUM CHLORIDE 
    sodium chloride irrigant
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-0051
    Route of AdministrationIRRIGATION
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE9 g  in 1000 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0338-0051-441000 mL in 1 BAG; Type 0: Not a Combination Product05/17/1985
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDANDA01931905/17/1985
    Labeler - Baxter Healthcare Corporation (005083209)
    Establishment
    NameAddressID/FEIBusiness Operations
    Baxter Healthcare Corporation059140764MANUFACTURE(0338-0051) , ANALYSIS(0338-0051) , PACK(0338-0051) , LABEL(0338-0051) , STERILIZE(0338-0051)
    Establishment
    NameAddressID/FEIBusiness Operations
    Baxter Healthcare Corporation189326168ANALYSIS(0338-0051) , MANUFACTURE(0338-0051) , LABEL(0338-0051) , PACK(0338-0051) , STERILIZE(0338-0051)
    Establishment
    NameAddressID/FEIBusiness Operations
    Baxter Healthcare Corporation194684502ANALYSIS(0338-0051)